Search - tctmd.com

Displaying 441 - 460 of 570

Sort: Relevancy | Date

News Industry News

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

February 25, 2019

News Daily News

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

Todd Neale

January 29, 2019

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

L.A. McKeown

January 17, 2019

News Daily News

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

Todd Neale

January 09, 2019

News Daily News

Catheter Ablation Boosts Outcomes in Patients With A-fib and Heart Failure: Meta-analysis

Todd Neale

December 24, 2018

News Daily News

FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients

Yael L. Maxwell

December 05, 2018

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News AHA 2018

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

Yael L. Maxwell

November 12, 2018

News Conference News AHA 2018

Remission, Not Cure: No Weaning Off Meds for Dilated Cardiomyopathy Patients, Says TRED-HF

Shelley Wood

November 11, 2018

News Daily News

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Shelley Wood

November 02, 2018

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

News Daily News

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Michael O'Riordan

October 19, 2018

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

Presentation TCT 2018

Case #2: Septal Artery Rupture With Septal Infarction and Relief of LVOT Obstruction

Presenter: Sherif F. Nagueh, Hubert Seggewiss, John S. Douglas Jr, Valerian Fernandes, Vijay Iyer, Srihari S. Naidu, Nish Patel, Alexandre C. Zago

September 24, 2018

Presentation TCT 2018

Case #1: Severe LVOT Obstruction in a Symptomatic 20-Year Old Male Despite Maximized Medical Treatment

Presenter: Sherif F. Nagueh, Hubert Seggewiss, John S. Douglas Jr, Valerian Fernandes, Vijay Iyer, Srihari S. Naidu, Nish Patel, Alexandre C. Zago

September 24, 2018

News Conference News TCT 2018

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Yael L. Maxwell

September 23, 2018

News Conference News TCT 2018

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

Todd Neale

September 23, 2018

Presentation TCT 2018

State-of-the-Art: Latest Innovations in Durable LVADs

Presenter: Nir Uriel, Hadley Wilson, Ulrich P. Jorde

September 22, 2018

Presentation TCT 2018

Treatment of LV Aneurysms: Revivent

Presenter: James E. Udelson, Clyde W. Yancy, Horst Sievert

September 22, 2018

Presentation TCT 2018

Percutaneous Ventricular Reshaping of the LV for Chronic Heart Failure: Ancora

Presenter: James E. Udelson, Clyde W. Yancy, Daniel Burkhoff

September 22, 2018

Advertisement

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

Catheter Ablation Boosts Outcomes in Patients With A-fib and Heart Failure: Meta-analysis

FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

Remission, Not Cure: No Weaning Off Meds for Dilated Cardiomyopathy Patients, Says TRED-HF

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Case #2: Septal Artery Rupture With Septal Infarction and Relief of LVOT Obstruction

Case #1: Severe LVOT Obstruction in a Symptomatic 20-Year Old Male Despite Maximized Medical Treatment

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

State-of-the-Art: Latest Innovations in Durable LVADs

Treatment of LV Aneurysms: Revivent

Percutaneous Ventricular Reshaping of the LV for Chronic Heart Failure: Ancora

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content